These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 38806846)

  • 1. The CRISPR/Cas system as an antimicrobial resistance strategy in aquatic ecosystems.
    Gupta SS; Hamza Kh M; Sones CL; Zhang X; Sivaraman GK
    Funct Integr Genomics; 2024 May; 24(3):110. PubMed ID: 38806846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR in Modulating Antibiotic Resistance of ESKAPE Pathogens.
    Saha U; Gondi R; Patil A; Saroj SD
    Mol Biotechnol; 2023 Jan; 65(1):1-16. PubMed ID: 35939207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to Overcome Antimicrobial Resistance in Nosocomial Infections, A Review and Update.
    Bakhtiyari N; Farajnia S; Ghasemali S; Farajnia S; Pormohammad A; Saeidvafa S
    Infect Disord Drug Targets; 2024; 24(6):e260124226226. PubMed ID: 38284691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRISPR-Cas, a Revolution in the Treatment and Study of ESKAPE Infections: Pre-Clinical Studies.
    González de Aledo M; González-Bardanca M; Blasco L; Pacios O; Bleriot I; Fernández-García L; Fernández-Quejo M; López M; Bou G; Tomás M
    Antibiotics (Basel); 2021 Jun; 10(7):. PubMed ID: 34206474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of CRISPR-Cas system in the diagnosis and therapy of ESKAPE infections.
    Qian Y; Zhou D; Li M; Zhao Y; Liu H; Yang L; Ying Z; Huang G
    Front Cell Infect Microbiol; 2023; 13():1223696. PubMed ID: 37662004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of Antimicrobial Resistance and Virulence Genes within the Prophage-Associated Regions in Nosocomial Pathogens.
    Kondo K; Kawano M; Sugai M
    mSphere; 2021 Aug; 6(4):e0045221. PubMed ID: 34232073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CRISPR-Cas System: A New Dawn to Combat Antibiotic Resistance.
    Rafiq MS; Shabbir MA; Raza A; Irshad S; Asghar A; Maan MK; Gondal MA; Hao H
    BioDrugs; 2024 May; 38(3):387-404. PubMed ID: 38605260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repurposing prokaryotic clustered regularly interspaced short palindromic repeats-Cas adaptive immune system to combat antimicrobial resistance.
    Devi V; Harjai K; Chhibber S
    Future Microbiol; 2023 May; 18():443-459. PubMed ID: 37317864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent Advances in Understanding the Molecular Mechanisms of Multidrug Resistance and Novel Approaches of CRISPR/Cas9-Based Genome-Editing to Combat This Health Emergency.
    Allemailem KS
    Int J Nanomedicine; 2024; 19():1125-1143. PubMed ID: 38344439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of CRISPR-Cas Immune Systems in Healthcare-Related Pathogens.
    Mortensen K; Lam TJ; Ye Y
    Front Microbiol; 2021; 12():758782. PubMed ID: 34759910
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resensitizing tigecycline- and colistin-resistant
    Zhang H; Chen B; Wang Z; Peng K; Liu Y; Wang Z
    Microbiol Spectr; 2024 Apr; 12(4):e0388423. PubMed ID: 38385691
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-cas system: biological function in microbes and its use to treat antimicrobial resistant pathogens.
    Shabbir MAB; Shabbir MZ; Wu Q; Mahmood S; Sajid A; Maan MK; Ahmed S; Naveed U; Hao H; Yuan Z
    Ann Clin Microbiol Antimicrob; 2019 Jul; 18(1):21. PubMed ID: 31277669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. From resistance to remedy: the role of clustered regularly interspaced short palindromic repeats system in combating antimicrobial resistance-a review.
    Raza A; Fatima P; Yasmeen B; Rana ZA; Ellakwa DE
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; ():. PubMed ID: 39404843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR-Based Gene Editing in
    Junaid M; Thirapanmethee K; Khuntayaporn P; Chomnawang MT
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From Gene Editing to Biofilm Busting: CRISPR-CAS9 Against Antibiotic Resistance-A Review.
    Pandey P; Vavilala SL
    Cell Biochem Biophys; 2024 Jun; 82(2):549-560. PubMed ID: 38702575
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.
    Vrancianu CO; Gheorghe I; Dobre EG; Barbu IC; Cristian RE; Popa M; Lee SH; Limban C; Vlad IM; Chifiriuc MC
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse Association between the Existence of CRISPR/Cas Systems with Antibiotic Resistance, Extended Spectrum β-Lactamase and Carbapenemase Production in Multidrug, Extensive Drug and Pandrug-Resistant
    Jwair NA; Al-Ouqaili MTS; Al-Marzooq F
    Antibiotics (Basel); 2023 May; 12(6):. PubMed ID: 37370299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas inhibits plasmid transfer and immunizes bacteria against antibiotic resistance acquisition in manure.
    Upreti C; Kumar P; Durso LM; Palmer KL
    Appl Environ Microbiol; 2024 Sep; 90(9):e0087624. PubMed ID: 39158272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diversity of antimicrobial-resistant pathogens from a freshwater ornamental fish farm.
    Preena PG; Arathi D; Raj NS; Arun Kumar TV; Arun Raja S; Reshma RN; Raja Swaminathan T
    Lett Appl Microbiol; 2020 Jul; 71(1):108-116. PubMed ID: 31602688
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitizing pathogens to antibiotics using the CRISPR-Cas system.
    Goren M; Yosef I; Qimron U
    Drug Resist Updat; 2017 Jan; 30():1-6. PubMed ID: 28363331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.